Landmark Study Shows GeneSight Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder
Assurex Health, a wholly-owned subsidiary of Myriad Genetics (NASDAQ:MYGN), today announced that results from a large, well-controlled pharmacogenomics study in patients with major depressive disorder were presented at the American Psychiatric Association annual meeting in New York City. The key finding is that patients were 50 percent more likely to achieve remission and 30 percent …
Assurex Health, a wholly-owned subsidiary of Myriad Genetics (NASDAQ:MYGN), today announced that results from a large, well-controlled pharmacogenomics study in patients with major depressive disorder were presented at the American Psychiatric Association annual meeting in New York City. The key finding is that patients were 50 percent more likely to achieve remission and 30 percent more likely to respond to treatment when their medication selection was guided by the GeneSight Psychotropic genetic test.
As quoted in the press release:
“We now have the results from the largest-ever pharmacogenomics clinical study in patients with moderate-to-very severe depression,” said Bryan Dechairo, Ph.D., executive vice president of clinical development, Myriad Genetics. “The important news here is that when doctors used the GeneSight genetic test to guide their selection of antidepressants, patients experienced significantly higher rates of response and remission as well as better overall symptom relief.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1816.34 | -2.48 | |
Silver | 20.81 | +0.06 | |
Copper | 3.74 | -0.04 | |
Palladium | 1957.00 | -5.00 | |
Platinum | 918.00 | -1.00 | |
Oil | 109.62 | -0.16 | |
Heating Oil | 3.89 | -0.07 | |
Natural Gas | 6.51 | +0.01 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.